PNORS Indonesia
As a leading provider of EDI technology and hosted solutions to businesses across Australasia, PNORS Technology Group has been involved in researching the Indonesian Health sector to determine where best to assist the Indonesian Government’s nationwide initiative to introduce Electronic Data Interchange (EDI) solutions to supply chain management. Two areas that have been identified as being of particular urgency are introducing technology to curtail the circulation of expired and/or counterfeit drugs in the supply chain and also the lack of inventory. The desired result will be to take real and measurable steps towards building an innovative and technology-driven B2B clearing-house platform in the Indonesian healthcare sector.
In September 2016, a historical Memorandum of Understanding was signed with the Government of Indonesia’s Agency for the Assessment and Application of Technology (BPPT) in response to the Government’s overall initiative to introduce eCommerce into the Health Sector.
The agency, under the coordination of the Ministry of Research and Technology, is mandated to assess, develop and implement technology to enhance delivery of services by all Government departments. In this instance, BPPT have acknowledged that PNORS already provide the optimal model in providing international best practices around e-procurement to health care providers in our region.
BPPT views the application of information and communication technology (ICT) as an integral part of achieving better health services for Indonesian citizens. Transaction transparency and improved efficiency will be achieved by integrating Indonesia’s existing e-catalogue for medical supplies to ensure data integrity and adherence to international standards, and providing software to automate communications between hospitals and suppliers using EDI.
Our cooperation with BPPT is an exchange of information, coupled with the introduction of international standards in e-procurement and electronic data interchange (EDI) between businesses within the health sector including hospitals, health centres, local government and the pharmaceutical industry.
A pilot program using an Indonesian hospital and their suppliers as a reference site is set to commence in April, 2017.
